Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Sharing the Story of the Cardiac Rehab Patient Experience: A QUALITATIVE STUDY.

Ellis JM, Freeman JT, Midgette EP, Sanghvi AP, Sarathy B, Johnson CG, Greenway SB, Whited MC.

J Cardiopulm Rehabil Prev. 2019 Jul;39(4):E13-E15. doi: 10.1097/HCR.0000000000000429.

PMID:
31241522
2.

Geographical and temporal clustering of OXA-48-producing Escherichia coli ST410 causing community-onset urinary tract infection in Christchurch, New Zealand.

Howard JC, Anderson T, Creighton J, Freeman JT.

J Antimicrob Chemother. 2018 Oct 1;73(10):2900-2901. doi: 10.1093/jac/dky269. No abstract available.

PMID:
29982524
3.

Inappropriate prescribing of antibiotics following discharge after major surgery: an area for improvement.

De Almeida M, Gerard C, Freeman JT, Duffy E, Roberts SA.

N Z Med J. 2018 May 18;131(1475):35-43.

PMID:
29771900
4.

An Exploration of the Impact of the "Open Gym" Scheduling Model of Cardiovascular Rehabilitation on Completion, Attendance, and Health Outcomes.

Whited MC, Ellis JM, Freeman JT, Corson AT, Greenway SB, Busch AM, Whited AL, Sears SF.

J Cardiopulm Rehabil Prev. 2019 Jan;39(1):E1-E2. doi: 10.1097/HCR.0000000000000312.

PMID:
29757822
5.

Antifungal susceptibility testing results of New Zealand yeast isolates, 2001-2015: Impact of recent CLSI breakpoints and epidemiological cut-off values for Candida and other yeast species.

Morris AJ, Rogers K, McKinney WP, Roberts SA, Freeman JT.

J Glob Antimicrob Resist. 2018 Sep;14:72-77. doi: 10.1016/j.jgar.2018.02.014. Epub 2018 Feb 24.

PMID:
29486358
6.

Hospital-Onset MRSA Bacteremia Rates Are Significantly Correlated With Sociodemographic Factors: A Step Toward Risk Adjustment.

Freeman JT, Blakiston MR, Anderson DJ.

Infect Control Hosp Epidemiol. 2018 Apr;39(4):479-481. doi: 10.1017/ice.2018.12. Epub 2018 Feb 19.

PMID:
29457569
7.

Antifungal susceptibility results of vaginal yeast isolates from New Zealand women, 2001-2015.

Morris AJ, McKinney WP, Rogers K, Roberts SA, Freeman JT.

N Z Med J. 2017 Nov 10;130(1465):112-115. No abstract available.

PMID:
29121632
8.

Life Values as an Intrinsic Guide for Cardiopulmonary Rehabilitation Program Engagement: A QUALITATIVE ANALYSIS.

Ellis JM, Whited MC, Freeman JT, Corson AT, Jameson JP, Greenway S, Sager DM, Midgette EP, Varju EV.

J Cardiopulm Rehabil Prev. 2018 Sep;38(5):309-313. doi: 10.1097/HCR.0000000000000295.

9.

Household transmission of NDM-producing E. coli in New Zealand.

Blakiston M, Roberts SA, Freeman JT, Heffernan H.

N Z Med J. 2017 Mar 24;130(1452):63-65.

PMID:
28337042
10.

Draft Genome Sequence of a Drug-Susceptible New Zealand Isolate of Mycobacterium tuberculosis Lineage 3.

Mac Aogáin M, Bower JE, Basu I, Freeman JT, O'Toole RF.

Genome Announc. 2015 May 21;3(3). pii: e00499-15. doi: 10.1128/genomeA.00499-15.

11.

Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand.

Rogers BA, Ingram PR, Runnegar N, Pitman MC, Freeman JT, Athan E, Havers S, Sidjabat HE, Gunning E, De Almeida M, Styles K, Paterson DL; ASID CRN.

Int J Antimicrob Agents. 2015 Apr;45(4):351-8. doi: 10.1016/j.ijantimicag.2014.11.015. Epub 2015 Jan 13.

PMID:
25707371
12.

Differences in risk-factor profiles between patients with ESBL-producing Escherichia coli and Klebsiella pneumoniae: a multicentre case-case comparison study.

Freeman JT, Rubin J, McAuliffe GN, Peirano G, Roberts SA, Drinković D, Pitout JD.

Antimicrob Resist Infect Control. 2014 Sep 1;3:27. doi: 10.1186/2047-2994-3-27. eCollection 2014.

13.
14.

Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in New Zealand.

O'Toole RF, Johari BM, Mac Aogáin M, Rogers TR, Bower JE, Basu I, Freeman JT.

Genome Announc. 2014 May 8;2(3). pii: e00319-14. doi: 10.1128/genomeA.00319-14.

15.

Clostridium difficile as a cause of healthcare-associated diarrhoea among children in Auckland, New Zealand: clinical and molecular epidemiology.

Sathyendran V, McAuliffe GN, Swager T, Freeman JT, Taylor SL, Roberts SA.

Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1741-7. doi: 10.1007/s10096-014-2139-2. Epub 2014 May 9.

PMID:
24810967
16.

Predictors of hospital surface contamination with Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: patient and organism factors.

Freeman JT, Nimmo J, Gregory E, Tiong A, De Almeida M, McAuliffe GN, Roberts SA.

Antimicrob Resist Infect Control. 2014 Feb 4;3(1):5. doi: 10.1186/2047-2994-3-5.

17.

Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries.

Rogers BA, Ingram PR, Runnegar N, Pitman MC, Freeman JT, Athan E, Havers SM, Sidjabat HE, Jones M, Gunning E, De Almeida M, Styles K, Paterson DL; Australasian Society for Infectious Diseases Clinical Research Network.

Antimicrob Agents Chemother. 2014;58(4):2126-34. doi: 10.1128/AAC.02052-13. Epub 2014 Jan 27.

18.

Widespread dissemination of CTX-M-15 genotype extended-spectrum-β-lactamase-producing enterobacteriaceae among patients presenting to community hospitals in the southeastern United States.

Chen LF, Freeman JT, Nicholson B, Keiger A, Lancaster S, Joyce M, Woods CW, Cook E, Adcock L, Louis S, Cromer AL, Sexton DJ, Anderson DJ.

Antimicrob Agents Chemother. 2014;58(2):1200-2. doi: 10.1128/AAC.01099-13. Epub 2013 Nov 18.

19.

Severe Clostridium difficile infection in New Zealand associated with an emerging strain, PCR-ribotype 244.

De Almeida MN, Heffernan H, Dervan A, Bakker S, Freeman JT, Bhally H, Taylor SL, Riley TV, Roberts SA.

N Z Med J. 2013 Aug 16;126(1380):9-14.

PMID:
24126745
20.

Bacteroides fragilis concealed in an infant with Escherichia coli meningitis.

Ganeshalingham A, Buckley D, Shaw I, Freeman JT, Wilson F, Best E.

J Paediatr Child Health. 2014 Jan;50(1):78-80. doi: 10.1111/jpc.12394. Epub 2013 Oct 9.

PMID:
24118618
21.
22.

Clinical and molecular correlates of virulence in Escherichia coli causing bloodstream infection following transrectal ultrasound-guided (TRUS) prostate biopsy.

Williamson DA, Freeman JT, Porter S, Roberts S, Wiles S, Paterson DL, Johnson JR.

J Antimicrob Chemother. 2013 Dec;68(12):2898-906. doi: 10.1093/jac/dkt276. Epub 2013 Jul 5.

PMID:
23833184
23.

Rectal colonization with New Delhi metallo-β-lactamase-1-producing Escherichia coli prior to transrectal ultrasound (TRUS)-guided prostate biopsy.

Williamson DA, Freeman JT, Roberts SA, Heffernan H, Dyet K, Paterson DL, Rogers BA, Sidjabat HE, Masters J.

J Antimicrob Chemother. 2013 Dec;68(12):2957-9. doi: 10.1093/jac/dkt266. Epub 2013 Jul 3. No abstract available.

PMID:
23825384
24.

Molecular epidemiology of human tuberculosis in New Zealand and potential insights for disease control.

O'Toole RF, Freeman JT.

N Z Med J. 2013 Apr 19;126(1373):100-2. No abstract available.

PMID:
23797087
25.

Enterococcus species and the central line-associated bloodstream infection surveillance definition: evaluating the importance of blood culture contamination.

Freeman JT, Anderson DJ, Sexton DJ.

Infect Control Hosp Epidemiol. 2013 Jul;34(7):762-3. doi: 10.1086/671009. No abstract available.

PMID:
23739086
26.

The Mark Coventry Award: Higher tissue concentrations of vancomycin with low-dose intraosseous regional versus systemic prophylaxis in TKA: a randomized trial.

Young SW, Zhang M, Freeman JT, Mutu-Grigg J, Pavlou P, Moore GA.

Clin Orthop Relat Res. 2014 Jan;472(1):57-65. doi: 10.1007/s11999-013-3038-z.

27.

Phylogenetic lineages of tuberculosis isolates in New Zealand and their association with patient demographics.

Yen S, Bower JE, Freeman JT, Basu I, O'Toole RF.

Int J Tuberc Lung Dis. 2013 Jul;17(7):892-7. doi: 10.5588/ijtld.12.0795. Epub 2013 Apr 30.

PMID:
23635796
28.

Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli.

Williamson DA, Barrett LK, Rogers BA, Freeman JT, Hadway P, Paterson DL.

Clin Infect Dis. 2013 Jul;57(2):267-74. doi: 10.1093/cid/cit193. Epub 2013 Mar 26. Review.

PMID:
23532481
29.

Central line-associated bloodstream infections in adult hematology patients with febrile neutropenia: an evaluation of surveillance definitions using differential time to blood culture positivity.

Freeman JT, Elinder-Camburn A, McClymont C, Anderson DJ, Bilkey M, Williamson DA, Berkahn L, Roberts SA.

Infect Control Hosp Epidemiol. 2013 Jan;34(1):89-92. doi: 10.1086/668431. Epub 2012 Nov 20.

30.

An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis.

Williamson DA, Basu I, Bower J, Freeman JT, Henderson G, Roberts SA.

Diagn Microbiol Infect Dis. 2012 Oct;74(2):207-9. doi: 10.1016/j.diagmicrobio.2012.06.013. Epub 2012 Jul 20.

PMID:
22819240
31.

Higher cefazolin concentrations with intraosseous regional prophylaxis in TKA.

Young SW, Zhang M, Freeman JT, Vince KG, Coleman B.

Clin Orthop Relat Res. 2013 Jan;471(1):244-9. doi: 10.1007/s11999-012-2469-2.

32.

When should contact precautions and active surveillance be used to manage patients with multidrug-resistant enterobacteriaceae?

Freeman JT, Williamson DA, Anderson DJ.

Infect Control Hosp Epidemiol. 2012 Jul;33(7):753-6. doi: 10.1086/666333. Epub 2012 May 9. No abstract available.

PMID:
22669239
33.

Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals.

Williamson DA, Sidjabat HE, Freeman JT, Roberts SA, Silvey A, Woodhouse R, Mowat E, Dyet K, Paterson DL, Blackmore T, Burns A, Heffernan H.

Int J Antimicrob Agents. 2012 Jun;39(6):529-33. doi: 10.1016/j.ijantimicag.2012.02.017. Epub 2012 Apr 21.

PMID:
22526013
34.

Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen.

Williamson DA, Roberts SA, Paterson DL, Sidjabat H, Silvey A, Masters J, Rice M, Freeman JT.

Clin Infect Dis. 2012 May;54(10):1406-12. doi: 10.1093/cid/cis194. Epub 2012 Mar 14.

PMID:
22419681
35.

Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.

Freeman JT, McBride SJ, Nisbet MS, Gamble GD, Williamson DA, Taylor SL, Holland DJ.

Int J Infect Dis. 2012 May;16(5):e371-4. doi: 10.1016/j.ijid.2012.01.008. Epub 2012 Mar 7.

36.

Screening for Mycobacterium tuberculosis infection among healthcare workers in New Zealand: prospective comparison between the tuberculin skin test and the QuantiFERON-TB Gold In-Tube assay.

Freeman JT, Marshall RJ, Newton S, Austin P, Taylor S, Chew TC, Gavaghan S, Roberts SA.

N Z Med J. 2012 Feb 10;125(1349):21-9.

PMID:
22327155
37.

Mycotic abdominal aortic aneurysm caused by toxigenic Clostridium difficile.

Sathyendran V, Riley TV, Roberts SA, Freeman JT.

Anaerobe. 2012 Jun;18(3):270-2. doi: 10.1016/j.anaerobe.2012.01.006. Epub 2012 Jan 31.

PMID:
22306098
38.

Comparative epidemiology of CTX-M-14 and CTX-M-15 producing Escherichia coli: association with distinct demographic groups in the community in New Zealand.

Freeman JT, Williamson DA, Heffernan H, Smith M, Bower JE, Roberts SA.

Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):2057-60. doi: 10.1007/s10096-011-1540-3. Epub 2012 Jan 23.

PMID:
22271302
39.

Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis.

Williamson DA, Roberts SA, Bower JE, Vaughan R, Newton S, Lowe O, Lewis CA, Freeman JT.

Int J Tuberc Lung Dis. 2012 Feb;16(2):216-20. doi: 10.5588/ijtld.11.0178.

PMID:
22137551
40.

Intercontinental transfer of OXA-181-producing Klebsiella pneumoniae into New Zealand.

Williamson DA, Heffernan H, Sidjabat H, Roberts SA, Paterson DL, Smith M, Freeman JT.

J Antimicrob Chemother. 2011 Dec;66(12):2888-90. doi: 10.1093/jac/dkr396. Epub 2011 Sep 19. No abstract available.

PMID:
21933789
41.

High rates of susceptibility to ceftazidime among globally prevalent CTX-M-producing Escherichia coli: potential clinical implications of the revised CLSI interpretive criteria.

Williamson DA, Roberts SA, Smith M, Heffernan H, Tiong A, Pope C, Freeman JT.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):821-4. doi: 10.1007/s10096-011-1380-1. Epub 2011 Sep 6.

PMID:
21894534
42.

Epidemic strains of Clostridium difficile are present in Auckland, New Zealand.

Roberts S, Heffernan H, Al Anbuky N, Richardson A, Swager T, Taylor SL, Bower J, Williamson D, Freeman JT.

N Z Med J. 2011 Apr 15;124(1332):97-101. No abstract available.

PMID:
21747433
43.

Extensively drug-resistant tuberculosis: New Zealand's first case and the challenges of management in a low-prevalence country.

Goh TL, Towns CR, Jones KL, Freeman JT, Wong CS.

Med J Aust. 2011 Jun 6;194(11):602-4.

PMID:
21644877
44.

Corynebacterium diphtheriae endocarditis: a case series and review of the treatment approach.

Muttaiyah S, Best EJ, Freeman JT, Taylor SL, Morris AJ, Roberts SA.

Int J Infect Dis. 2011 Sep;15(9):e584-8. doi: 10.1016/j.ijid.2011.04.003. Epub 2011 Jun 8. Review.

45.

Blood culture contamination with Enterococci and skin organisms: implications for surveillance definitions of primary bloodstream infections.

Freeman JT, Chen LF, Sexton DJ, Anderson DJ.

Am J Infect Control. 2011 Jun;39(5):436-438. doi: 10.1016/j.ajic.2010.07.014. Epub 2011 Jan 15.

PMID:
21239084
46.

Surgical site infections following bariatric surgery in community hospitals: a weighty concern?

Freeman JT, Anderson DJ, Hartwig MG, Sexton DJ.

Obes Surg. 2011 Jul;21(7):836-40. doi: 10.1007/s11695-010-0105-3.

PMID:
20198452
47.

Seasonal peaks in Escherichia coli infections: possible explanations and implications.

Freeman JT, Anderson DJ, Sexton DJ.

Clin Microbiol Infect. 2009 Oct;15(10):951-3. doi: 10.1111/j.1469-0691.2009.02866.x.

48.
49.

Community-onset genitourinary tract infection due to CTX-M-15-Producing Escherichia coli among travelers to the Indian subcontinent in New Zealand.

Freeman JT, McBride SJ, Heffernan H, Bathgate T, Pope C, Ellis-Pegler RB.

Clin Infect Dis. 2008 Sep 1;47(5):689-92. doi: 10.1086/590941.

PMID:
18665816
50.

Agerasia--need aging wither one?

Freeman JT.

Pharos Alpha Omega Alpha Honor Med Soc. 1989 Winter;52(1):36. No abstract available.

PMID:
2734359

Supplemental Content

Loading ...
Support Center